We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT02826486
Brief Title: Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients (COMBAT/KEYNOTE-202) (COMBAT)

First Submitted : June 21, 2016
First Submitted that Met QC Criteria : July 5, 2016
First Posted : July 11, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : January 1, 2023
Last Update Posted : January 4, 2023